HK1255074A1 - 生長抑素調節劑及其用途 - Google Patents

生長抑素調節劑及其用途

Info

Publication number
HK1255074A1
HK1255074A1 HK18114203.4A HK18114203A HK1255074A1 HK 1255074 A1 HK1255074 A1 HK 1255074A1 HK 18114203 A HK18114203 A HK 18114203A HK 1255074 A1 HK1255074 A1 HK 1255074A1
Authority
HK
Hong Kong
Prior art keywords
somatostatin modulators
somatostatin
modulators
Prior art date
Application number
HK18114203.4A
Other languages
English (en)
Inventor
Jian Zhao
Yunfei Zhu
Shimiao Wang
Sangdon Han
Sun Hee Kim
Original Assignee
Crinetics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinetics Pharmaceuticals Inc filed Critical Crinetics Pharmaceuticals Inc
Publication of HK1255074A1 publication Critical patent/HK1255074A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK18114203.4A 2015-07-01 2018-11-07 生長抑素調節劑及其用途 HK1255074A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562187606P 2015-07-01 2015-07-01
PCT/US2016/038155 WO2017003724A1 (en) 2015-07-01 2016-06-17 Somatostatin modulators and uses thereof

Publications (1)

Publication Number Publication Date
HK1255074A1 true HK1255074A1 (zh) 2019-08-02

Family

ID=57608634

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114203.4A HK1255074A1 (zh) 2015-07-01 2018-11-07 生長抑素調節劑及其用途

Country Status (4)

Country Link
US (1) US9902703B2 (zh)
EP (1) EP3317278B1 (zh)
HK (1) HK1255074A1 (zh)
WO (1) WO2017003724A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8308040B2 (en) 2007-06-22 2012-11-13 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with an articulatable end effector
WO2017003724A1 (en) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
WO2017205536A2 (en) * 2016-05-24 2017-11-30 Genentech, Inc. Therapeutic compounds and uses thereof
SG11201900349VA (en) 2016-07-14 2019-02-27 Crinetics Pharmaceuticals Inc Somatostatin modulators and uses thereof
AU2018219644A1 (en) 2017-02-08 2019-08-29 Ono Pharmaceutical Co., Ltd. Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
EP3658560A4 (en) * 2017-07-25 2021-01-06 Crinetics Pharmaceuticals, Inc. SOMATOSTAT IN MODULATORS AND USES THEREOF
WO2019143718A1 (en) * 2018-01-17 2019-07-25 Crinetics Pharmaceuticals, Inc. Process of making somatostatin modulators
MX2023002761A (es) 2020-09-09 2023-04-03 Crinetics Pharmaceuticals Inc Formulaciones de un modulador de somatostatina.

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
WO1993004047A1 (en) 1991-08-16 1993-03-04 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
IL102764A0 (en) 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
WO1993022292A1 (en) 1992-05-07 1993-11-11 Merck & Co., Inc. New quinazolines as inhibitors of hiv reverse transcriptase
WO1995012583A1 (en) 1993-11-05 1995-05-11 Merck & Co., Inc. New quinazolines as inhibitors of hiv reverse transcriptase
CZ292806B6 (cs) 1996-08-06 2003-12-17 Pfizer Inc. Pyrido- nebo pyrimido-6,6- nebo -6,7-bicyklické deriváty, farmaceutické kompozice na jejich bázi
US6124302A (en) 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
JP2002509922A (ja) 1998-03-27 2002-04-02 デュポン ファーマシューティカルズ カンパニー ４，４−二置換−３，４−ジヒドロ−２（１ｈ）−キナゾリンチオン誘導体、それらの調製法、およびｈｉｖ逆転写酵素阻害剤としてのそれらの使用
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6175009B1 (en) 1999-11-18 2001-01-16 Dupont Pharmaceuticals Company Process for the preparation of quinazolinones
WO2002081456A1 (en) 2001-03-28 2002-10-17 Bristol-Myers Squibb Company Cyanamide, alkoxyamino, and urea derivatives of 4, 4-disubstituted-3, 4-dihydro-2 (1h)- quinazolinones as hiv reverse transcriptase inhibitors
US20030158188A1 (en) 2002-02-20 2003-08-21 Chih-Hung Lee Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7015233B2 (en) 2003-06-12 2006-03-21 Abbott Laboratories Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
US7763616B2 (en) 2005-02-16 2010-07-27 Schering Corporation Piperazine-piperidines with CXCR3 antagonist activity
WO2006090272A1 (en) 2005-02-22 2006-08-31 Warner-Lambert Company Llc Isoquinoline [1,8]naphthyridin-2-ones and related compounds for treatment of schizophrenia
US8802840B2 (en) 2005-03-08 2014-08-12 Biota Scientific Management Pty Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
US8686002B2 (en) 2005-08-21 2014-04-01 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
AU2007309708A1 (en) 2006-03-13 2008-05-02 Merck Sharp & Dohme Corp. Somatostatin agonists
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US20080027044A1 (en) 2006-06-13 2008-01-31 Kim Lewis Prodrug antibiotic screens
WO2007149476A2 (en) 2006-06-19 2007-12-27 Trustees Of Columbia University In The City Of New York Assays for non-apoptotic cell death and uses thereof
WO2008008650A1 (en) 2006-07-10 2008-01-17 Indiana University Research And Technology Corporation Methods for treating cystic kidney diseases
US8093299B2 (en) 2007-03-30 2012-01-10 Amgen Inc. Methods of treating bowel disorders
WO2008129276A1 (en) 2007-04-19 2008-10-30 Boehringer Ingelheim International Gmbh Disulfonamides useful in the treatment of inflammation
US8772047B2 (en) 2007-05-22 2014-07-08 Becton, Dickinson And Company Dyes having ratiometric fluorescence response for detecting metabolites
WO2008154332A1 (en) 2007-06-06 2008-12-18 Becton, Dickinson And Company Near-infrared dyes as surface enhanced raman scattering reporters
US20080308770A1 (en) 2007-06-14 2008-12-18 Laxmikant Tiwari Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
US8685962B2 (en) 2007-07-02 2014-04-01 Technion Research & Development Foundation Limited Compositions, articles and methods comprising TSPO ligands for preventing or reducing tobacco-associated damage
DE102007032739A1 (de) * 2007-07-13 2009-01-15 Merck Patent Gmbh Chinazolinamidderivate
CA2701406C (en) 2007-10-05 2016-01-26 Banyu Pharmaceutical Co., Ltd. Benzoxazinone derivative
JP2011514348A (ja) 2008-03-03 2011-05-06 アムジエン・インコーポレーテツド 胃酸過多障害の治療方法
MX2010010485A (es) 2008-03-28 2011-03-30 Amgen Inc Star Compuesto calcimimetico para su uso en el tratamiento de lesiones epiteliales.
GB0808948D0 (en) 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
WO2010059953A1 (en) 2008-11-20 2010-05-27 Purdue Research Foundation Quinazoline inhibitors of bace 1 and methods of using
JP2012513481A (ja) 2008-12-23 2012-06-14 プレジデント アンド フェロウズ オブ ハーバード カレッジ ネクロトーシスの小分子阻害剤
US20100210682A1 (en) 2009-02-19 2010-08-19 Abbott Laboratories Repeated Dosing of TRPV1 Antagonists
WO2010104882A1 (en) 2009-03-10 2010-09-16 Amgen Inc. Methods of modulating sperm motility
DE102009054302A1 (de) 2009-11-23 2011-05-26 Merck Patent Gmbh Chinazolinderivate
WO2012031383A1 (zh) 2010-09-06 2012-03-15 中国科学院广州生物医药与健康研究院 酰胺类化合物
WO2012116237A2 (en) 2011-02-23 2012-08-30 Intellikine, Llc Heterocyclic compounds and uses thereof
AU2012269643A1 (en) 2011-06-16 2014-02-06 AB Pharma Ltd. Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof
WO2013033268A2 (en) 2011-08-29 2013-03-07 Coferon, Inc. Bivalent bromodomain ligands, and methods of using same
JP2013091624A (ja) 2011-10-26 2013-05-16 Kowa Co Ｔｌｒ阻害作用を有するキナゾリン誘導体
US8642774B2 (en) 2011-12-08 2014-02-04 Boehringer Ingelheim International Gmbh Compounds
WO2014018891A1 (en) 2012-07-27 2014-01-30 Biogen Idec Ma Inc. Compounds that are s1p modulating agents and/or atx modulating agents
WO2014072930A2 (en) 2012-11-09 2014-05-15 Aurigene Discovery Technologies Limited Fused pyridine derivatives as antibacterial agents
US9765016B2 (en) 2013-01-29 2017-09-19 Biogen Ma Inc. S1P modulating agents
SG11201507371RA (en) 2013-03-14 2015-10-29 Alkermes Pharma Ireland Ltd Prodrugs of fumarates and their use in treating various deseases
WO2017003724A1 (en) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof

Also Published As

Publication number Publication date
US20170001966A1 (en) 2017-01-05
EP3317278B1 (en) 2021-04-14
EP3317278A4 (en) 2018-12-05
US9902703B2 (en) 2018-02-27
EP3317278A1 (en) 2018-05-09
WO2017003724A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
HK1255034A1 (zh) 生長抑素調節劑及其用途
ZA201900317B (en) Somatostatin modulators and uses thereof
IL247847A0 (en) ror gamma modulator and their use
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
IL269241A (en) Somatostatin modulators and their uses
HK1255074A1 (zh) 生長抑素調節劑及其用途
SG11201706029VA (en) Anti-senescence compounds and uses thereof
HK1246780A1 (zh) 氮雜-吡啶酮化合物及其用途
PL3303291T3 (pl) Modulatory ROR-gamma
PL3303293T3 (pl) Modulatory ROR-gamma
PL3303290T3 (pl) Modulatory ROR-gamma
ZA201705456B (en) Benzoxaborole compounds and uses thereof
PL3319942T3 (pl) MODULATORY ROR-GAMMA (RORγ)
GB201504763D0 (en) Compounds and uses
HK1247122A1 (zh) 組合及其用途
IL254241A0 (en) Etv2 and its uses
IL253459A0 (en) Isoergoline compounds and their uses
ZA201905511B (en) Rorgamma modulators and uses thereof
ZA201905513B (en) Rorgamma modulators and uses thereof
GB201718875D0 (en) Autophagy-inhibiting compounds and uses thereof
ZA201606656B (en) Ror-gamma modulators and uses thereof
GB201504273D0 (en) Overhood seal and use thereof